Business Wire

Aspect Announces CEO Leadership Transition and New Independent Board

Share

Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company.

As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026.

Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders.

“Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is about creating space for the right leadership to carry that vision forward. Our mission and culture remain intact, and I’m excited to see the company continue to grow and go even further.”

With Darryl’s support, the Board has appointed Jeff Kupietzky as Interim CEO while Aspect begins a search for its next permanent leader. Jeff is an experienced software industry executive with a strong track record of guiding enterprise technology companies through periods of transformation and growth. He most recently served as Interim CEO of Glassbox, a digital customer experience analytics provider.

“I’m honored to step in and lead Aspect at this moment,” said Jeff Kupietzky. “Aspect has a strong foundation, a talented team, and a grand vision. I look forward to working closely with the organization to build on that momentum, continue serving our customers and partners, and support the company through this next phase.”

New Independent Board of Directors

In conjunction with the leadership transition, Aspect announced the appointment of a new independent Board of Directors, bringing a combined 90 years of enterprise software, operations, and governance experience:

  • Tom Manning (Board Chair) – Tom Manning is the former Chairman and CEO of Dun & Bradstreet and a seasoned global executive with more than 40 years of leadership experience across data, IT services, enterprise software, and outsourcing. He currently serves as Chairman of Cresco Labs, a director of CommScope, and founder of Harvard Square Lab. He holds an MBA from Stanford University and an AB in East Asian Studies with honors from Harvard College.
  • Louis Summe – Louis Summe is a tech entrepreneur, best known as the Co-Founder and former CEO of LiveVox (NICE), a cloud contact center platform, bringing over 30 years of experience in developing enterprise customer engagement technology, with early career roots at EDS (HP Enterprise), Merck-Medco (Cigna), and Physicians Online (WebMD). He holds an MBA from Columbia Business School, is based in San Francisco, and also serves as Executive Chairman at VanillaSoft.
  • Nicole Anasenes – Nicole Anasenes is a seasoned operational executive with more than 20 years of experience scaling and transforming global technology companies. She has served as CFO and COO at ANSYS, Squarespace, and Infor, leading enterprise transformation, IPO readiness, and SaaS transitions. She currently serves on the boards of Motorola Solutions and Fidelity National Information Services (FIS) as Audit Chair, and holds an MBA from Wharton.

“As we step into Aspect’s next phase, a board that pairs operational rigor with strategic vision is essential,” said Tom Manning, Board Chair. “Nicole, Louis, and I have each scaled and unlocked the potential of mission-critical software companies. We look forward to combining our experience with Aspect’s momentum to accelerate the company’s existing strategies and long-term strategic vision to create value for our customers, partners, and people.”

Continuity and Outlook

Aspect confirms that this leadership transition willnot impact its services, delivery, or commercial agreements that customers, partners, and vendors rely upon. The company remains focused on helping organizations unlock the full potential of their workforce through intelligent, enterprise-grade workforce management solutions.

About Aspect

Aspect is a proven leader in Workforce Management, helping the world’s most complex organizations unlock the full potential of their workforce. Backed by over 50 years of innovation, Aspect delivers enterprise-grade solutions that combine forecasting, scheduling, performance management, and employee engagement into one intelligent platform. Powered by Aspect Intelligence, the platform transforms disconnected workforce data into predictive, actionable insights—enabling faster decisions, stronger teams, and better business outcomes. Trusted by global leaders in financial services, telecommunications, airlines, retail, and more, Aspect helps enterprises adapt in real time, control costs, and deliver exceptional service at scale. Learn more at www.aspect.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260106187555/en/

Contacts

Media Contact
Kelly Maiden
press@aspect.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release

Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye